Analyst David Adlington works at JPMORGAN and is focused on Healthcare, Communication Services sectors with 44 price targets and ratings documented since 2020 spanning on 4 stocks. Analyst's average stock valuation to be materialised ratio is 45% with an average time for price targets to be met of 60.5 days.
Most recent stock forecast was given on FMS, Fresenius Medical Care AG & Co. KGaA at 01-Nov-2022.
David Adlington best performing recommendations are on PHG.
The best stock recommendation documented was for PHG at 4/7/2020. The price target of $36.86 was fulfilled within 2 days with a profit of $1.33 (3.74%) receiving and performance score of 18.72.
Average potential price target upside
Currently, out of the existing stock ratings of David Adlington - 3947 which are a Hold (67.93%), 875 which are a Sell (15.06%), 988 which are a Buy (17.01%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
22
$1.23 (5.92%)
27
1 months 5 days ago
2/8 (25%)
$6.8 (22.40%)
263
Hold
24
4 months 25 days ago
0/5 (0%)
$27.3 (95.48%)
Hold
26.93
$6.16 (29.66%)
4 months 26 days ago
0/1 (0%)
$12.73 (89.65%)
Sell
17.06
$-3.71 (-17.86%)
23.51
4 months 27 days ago
1/6 (16.67%)
$21.3 (67.87%)
66
Hold
64.4
$43.63 (210.06%)
1 years 1 months 3 days ago
0/1 (0%)
$32.49 (101.82%)
